Pharma Excipients

News on Pharma Excipients

Melt Extrusion

Techniques to overcome poor aqueous solubility of active pharmaceutical ingredients (APIs) continue to gain interest, with a reported 30% of marketed compounds classified as BCS II and 10% classified as BCS IV. Approximately 70% of new…

Injectable Formulations of Poorly Water-Soluble Drugs

Each year, an increasing number of new molecular entities in the drug development pipeline are characterized as having poor water solubility. While solubility limitations are critically important in all formulations, failure to properly…